Search

everythinglearnresearchcommunity

for

Search:↓

Topical patidegib gel effectively treats basal cell carcinoma in Gorlin syndrome patients without causing the side effects seen with oral treatments.

Taking Dutasteride with Ketoconazole can increase Dutasteride's effects and side effects.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.

Childhood Alopecia Areata causes hair loss and requires varied treatments, with psychological support being crucial.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Blocking IL-8 can reduce skin rashes from cancer treatment.

SCD-153 shows promise as an effective topical treatment for alopecia areata.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Early diagnosis and thorough evaluation are crucial for better outcomes in alopecic sarcoidosis.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.